Sarepta Therapeutics, Inc. (SRPT)
21.03
+0.17
(+0.82%)
USD |
NASDAQ |
Aug 31, 16:00
21.07
+0.04
(+0.19%)
After-Hours: 20:00
Sarepta Therapeutics Cash from Operations (TTM) : 93.95M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.95M |
| March 31, 2026 | 158.22M |
| December 31, 2025 | -222.54M |
| September 30, 2025 | -257.43M |
| June 30, 2025 | -300.75M |
| March 31, 2025 | -547.15M |
| December 31, 2024 | -205.79M |
| September 30, 2024 | -352.49M |
| June 30, 2024 | -396.50M |
| March 31, 2024 | -533.67M |
| December 31, 2023 | -500.99M |
| September 30, 2023 | -538.73M |
| June 30, 2023 | -488.99M |
| March 31, 2023 | -433.57M |
| December 31, 2022 | -325.35M |
| September 30, 2022 | -262.28M |
| June 30, 2022 | -321.64M |
| March 31, 2022 | -363.98M |
| December 31, 2021 | -443.17M |
| September 30, 2021 | -588.38M |
| June 30, 2021 | -702.24M |
| March 31, 2021 | -700.70M |
| December 31, 2020 | 107.47M |
| September 30, 2020 | 113.87M |
| June 30, 2020 | 284.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 313.22M |
| December 31, 2019 | -460.80M |
| September 30, 2019 | -415.09M |
| June 30, 2019 | -460.98M |
| March 31, 2019 | -499.22M |
| December 31, 2018 | -388.66M |
| September 30, 2018 | -297.30M |
| June 30, 2018 | -241.88M |
| March 31, 2018 | -209.78M |
| December 31, 2017 | -232.00M |
| September 30, 2017 | -282.17M |
| June 30, 2017 | -284.88M |
| March 31, 2017 | -243.02M |
| December 31, 2016 | -245.82M |
| September 30, 2016 | -195.86M |
| June 30, 2016 | -181.56M |
| March 31, 2016 | -166.80M |
| December 31, 2015 | -149.46M |
| September 30, 2015 | -143.64M |
| June 30, 2015 | -132.65M |
| March 31, 2015 | -143.62M |
| December 31, 2014 | -128.54M |
| September 30, 2014 | -120.91M |
| June 30, 2014 | -105.47M |
| March 31, 2014 | -77.97M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| ImmunityBio, Inc. | -281.14M |
| X4 Pharmaceuticals, Inc. | -83.74M |
| MapLight Therapeutics, Inc. | -174.67M |